Literature DB >> 15374599

The antioxidant potential of Sutherlandia frutescens.

Antonio C Fernandes1, A Duncan Cromarty, Carl Albrecht, Constance E Jansen van Rensburg.   

Abstract

One of the best-known multi-purpose medicinal plants in Southern Africa, Sutherlandia frutescens subsp. microphylla (family: Fabaceae/Leguminosa), is used for a wide range of conditions, including cancer, viral diseases and inflammatory conditions. Little scientific data has been documented on the mechanism by which Sutherlandia frutescens acts on the immune system. Phagocyte derived reactive oxygen species, such as hydrogen peroxide and superoxide radicals, are responsible for the pathogenesis of various inflammatory conditions. Anti-inflammatory properties of various medicinal-plant extracts have been explained, at least in part, by their antioxidant activities. We investigated the effects of a hot water extract of Sutherlandia frutescens on both luminol and lucigenin enhanced chemiluminescence of neutrophils stimulated with L-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) as well as its superoxide and hydrogen peroxide scavenging properties in a cell free system. The results indicate that Sutherlandia frutescens extract possesses superoxide as well as hydrogen peroxide scavenging activities at concentrations as low as 10 microg/ml, which could account for some of the anti-inflammatory properties that have been described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374599     DOI: 10.1016/j.jep.2004.05.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

1.  Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2004-11-10

2.  Cycloartane glycosides from Sutherlandia frutescens.

Authors:  Xiang Fu; Xing-Cong Li; Troy J Smillie; Paulo Carvalho; Wilfred Mabusela; James Syce; Quinton Johnson; William Folk; Mitchell A Avery; Ikhlas A Khan
Journal:  J Nat Prod       Date:  2008-09-23       Impact factor: 4.050

3.  Immuno-stimulatory activity of a polysaccharide-enriched fraction of Sutherlandia frutescens occurs by the toll-like receptor-4 signaling pathway.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; Chi-Hua Lu; Valeri V Mossine; George E Rottinghaus; William R Folk; Grace Y Sun; Dennis B Lubahn; Kevin L Fritsche
Journal:  J Ethnopharmacol       Date:  2015-06-18       Impact factor: 4.360

4.  Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.

Authors:  Mukul Minocha; Nanda K Mandava; Deep Kwatra; Dhananjay Pal; William R Folk; Ravinder Earla; Ashim K Mitra
Journal:  Int J Pharm       Date:  2011-04-23       Impact factor: 5.875

5.  Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro.

Authors:  Mlungisi Ngcobo; Nceba Gqaleni; Paul K Chelule; Metse Serumula; Alain Assounga
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

6.  The immunomodulatory effects of Sutherlandia frutescens extracts in human normal peripheral blood mononuclear cells.

Authors:  Mlungisi Ngcobo; Nceba Gqaleni; Paul K Chelule; Metse Serumula; Alain Assounga
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-02-13

7.  Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.

Authors:  Wei Lei; Jimmy D Browning; Peggy A Eichen; Korey J Brownstein; William R Folk; Grace Y Sun; Dennis B Lubahn; George E Rottinghaus; Kevin L Fritsche
Journal:  Int Immunopharmacol       Date:  2015-11-12       Impact factor: 4.932

Review 8.  African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology.

Authors:  Edward Mills; Curtis Cooper; Dugald Seely; Izzy Kanfer
Journal:  Nutr J       Date:  2005-05-31       Impact factor: 3.271

9.  Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial.

Authors:  Douglas Wilson; Kathy Goggin; Karen Williams; Mary M Gerkovich; Nceba Gqaleni; James Syce; Patricia Bartman; Quinton Johnson; William R Folk
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

10.  A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults.

Authors:  Quinton Johnson; James Syce; Haylene Nell; Kevin Rudeen; William R Folk
Journal:  PLoS Clin Trials       Date:  2007-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.